{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:20:19Z","timestamp":1740144019431,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T00:00:00Z","timestamp":1500595200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s40257-017-0315-8","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T07:54:03Z","timestamp":1500623643000},"page":"845-846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Improvement of Rosacea During Acyclovir Treatment: A Case Report"],"prefix":"10.1007","volume":"18","author":[{"given":"Zohreh Sadat","family":"Badieyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9940-4571","authenticated-orcid":false,"given":"Sayed Shahabuddin","family":"Hoseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,21]]},"reference":[{"issue":"5","key":"315_CR1","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jaad.2014.08.028","volume":"72","author":"AM Two","year":"2015","unstructured":"Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015;72(5):749\u201358. doi:\n                        10.1016\/j.jaad.2014.08.028\n                        \n                     (quiz 59\u201360).","journal-title":"J Am Acad Dermatol."},{"issue":"1","key":"315_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jaad.2006.04.084","volume":"56","author":"EJ Zuuren van","year":"2007","unstructured":"van Zuuren EJ, Gupta AK, Gover MD, Graber M, Hollis S. Systematic review of rosacea treatments. J Am Acad Dermatol. 2007;56(1):107\u201315. doi:\n                        10.1016\/j.jaad.2006.04.084\n                        \n                    .","journal-title":"J Am Acad Dermatol"},{"key":"315_CR3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-1-4613-0381-7_45","volume":"398","author":"O Hayaishi","year":"1996","unstructured":"Hayaishi O. Utilization of superoxide anion by indoleamine oxygenase-catalyzed tryptophan and indoleamine oxidation. Adv Exp Med Biol. 1996;398:285\u20139.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"315_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nm.2092","volume":"16","author":"Y Wang","year":"2010","unstructured":"Wang Y, Liu H, McKenzie G, Witting PK, Stasch JP, Hahn M, et al. Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med. 2010;16(3):279\u201385. doi:\n                        10.1038\/nm.2092\n                        \n                    .","journal-title":"Nat Med"},{"issue":"Pt 6","key":"315_CR5","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/brain\/116.6.1425","volume":"116","author":"MP Heyes","year":"1993","unstructured":"Heyes MP, Saito K, Major EO, Milstien S, Markey SP, Vickers JH. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease: attenuation of synthesis from l-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Brain. 1993;116(Pt 6):1425\u201350.","journal-title":"Brain"},{"issue":"7","key":"315_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1211\/0022357056442","volume":"57","author":"AC Muller","year":"2005","unstructured":"Muller AC, Maharaj H, Maharaj DS, Daya S. Aciclovir protects against quinolinic-acid-induced oxidative neurotoxicity. J Pharm Pharmacol. 2005;57(7):883\u20138. doi:\n                        10.1211\/0022357056442\n                        \n                    .","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"315_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/jdv.12556","volume":"29","author":"Z Takci","year":"2015","unstructured":"Takci Z, Bilgili SG, Karadag AS, Kucukoglu ME, Selek S, Aslan M. Decreased serum paraoxonase and arylesterase activities in patients with rosacea. J Eur Acad Dermatol Venereol. 2015;29(2):367\u201370. doi:\n                        10.1111\/jdv.12556\n                        \n                    .","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1\u20133","key":"315_CR8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3940(99)00191-3","volume":"264","author":"J Haas","year":"1999","unstructured":"Haas J, Meyding-Lamade U, Fath A, Stingele K, Storch-Hagenlocher B, Wildemann B. Acyclovir treatment of experimentally induced herpes simplex virus encephalitis: monitoring the changes in immunologic NO synthase expression and viral load within brain tissue of SJL mice. Neurosci Lett. 1999;264(1\u20133):129\u201332.","journal-title":"Neurosci Lett"},{"issue":"1","key":"315_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/jidsymp.2011.7","volume":"15","author":"M Steinhoff","year":"2011","unstructured":"Steinhoff M, Buddenkotte J, Aubert J, Sulk M, Novak P, Schwab VD, et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):2\u201311. doi:\n                        10.1038\/jidsymp.2011.7\n                        \n                    .","journal-title":"J Investig Dermatol Symp Proc."},{"issue":"108","key":"315_CR10","first-page":"657","volume":"4","author":"G Sauermann","year":"1997","unstructured":"Sauermann G, Jaspers S, Hoppe U, Salzer B, Steinkraus V. Influence of NO-synthase antagonists in rosacea patients. J Invest Dermatol. 1997;4(108):657.","journal-title":"J Investig Dermatol."},{"issue":"2","key":"315_CR11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/bjo.2006.101121","volume":"91","author":"JR Smith","year":"2007","unstructured":"Smith JR, Lanier VB, Braziel RM, Falkenhagen KM, White C, Rosenbaum JT. Expression of vascular endothelial growth factor and its receptors in rosacea. Br J Ophthalmol. 2007;91(2):226\u20139. doi:\n                        10.1136\/bjo.2006.101121\n                        \n                    .","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"315_CR12","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1172\/JCI118962","volume":"98","author":"M Kuroki","year":"1996","unstructured":"Kuroki M, Voest EE, Amano S, Beerepoot LV, Takashima S, Tolentino M, et al. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest. 1996;98(7):1667\u201375. doi:\n                        10.1172\/JCI118962\n                        \n                    .","journal-title":"J Clin Investig"},{"issue":"7","key":"315_CR13","doi-asserted-by":"publisher","first-page":"e103185","DOI":"10.1371\/journal.pone.0103185","volume":"9","author":"H Lu","year":"2014","unstructured":"Lu H, Han YJ, Xu JD, Xing WM, Chen J. Proteomic characterization of acyclovir-induced nephrotoxicity in a mouse model. PLoS One. 2014;9(7):e103185. doi:\n                        10.1371\/journal.pone.0103185\n                        \n                    .","journal-title":"PLoS One"},{"key":"315_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.lfs.2015.01.036","volume":"127","author":"YJ Guo","year":"2015","unstructured":"Guo YJ, Luo T, Wu F, Mei YW, Peng J, Liu H, et al. Involvement of TLR2 and TLR9 in the anti-inflammatory effects of chlorogenic acid in HSV-1-infected microglia. Life Sci. 2015;127:12\u20138. doi:\n                        10.1016\/j.lfs.2015.01.036\n                        \n                    .","journal-title":"Life Sci"},{"issue":"5","key":"315_CR15","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1073\/pnas.0308057100","volume":"101","author":"EA Kurt-Jones","year":"2004","unstructured":"Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA. 2004;101(5):1315\u201320. doi:\n                        10.1073\/pnas.0308057100\n                        \n                    .","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-017-0315-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-017-0315-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-017-0315-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T07:32:40Z","timestamp":1510212760000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-017-0315-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,21]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["315"],"URL":"https:\/\/doi.org\/10.1007\/s40257-017-0315-8","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"type":"print","value":"1175-0561"},{"type":"electronic","value":"1179-1888"}],"subject":[],"published":{"date-parts":[[2017,7,21]]}}}